Harashima H - Search Results

1

Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core.

Nakamura T, Yamada K, Fujiwara Y, Sato Y, Harashima H. Nakamura T, et al. Among authors: harashima h. Mol Pharm. 2018 Jun 4;15(6):2142-2150. doi: 10.1021/acs.molpharmaceut.7b01166. Epub 2018 Apr 30. Mol Pharm. 2018. PMID: 29668291

2

Construction of a multifunctional envelope-type nano device by a SUV*-fusion method.

Sasaki K, Kogure K, Chaki S, Kihira Y, Ueno M, Harashima H. Sasaki K, et al. Among authors: harashima h. Int J Pharm. 2005 May 30;296(1-2):142-50. doi: 10.1016/j.ijpharm.2005.02.020. Epub 2005 Apr 11. Int J Pharm. 2005. PMID: 15885466

3

A multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids.

Moriguchi R, Kogure K, Akita H, Futaki S, Miyagishi M, Taira K, Harashima H. Moriguchi R, et al. Among authors: harashima h. Int J Pharm. 2005 Sep 14;301(1-2):277-85. doi: 10.1016/j.ijpharm.2005.05.021. Int J Pharm. 2005. PMID: 16019173

4

Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomes.

Futaki S, Masui Y, Nakase I, Sugiura Y, Nakamura T, Kogure K, Harashima H. Futaki S, et al. Among authors: harashima h. J Gene Med. 2005 Nov;7(11):1450-8. doi: 10.1002/jgm.796. J Gene Med. 2005. PMID: 16025556

5

Mitochondrial delivery of mastoparan with transferrin liposomes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy.

Yamada Y, Shinohara Y, Kakudo T, Chaki S, Futaki S, Kamiya H, Harashima H. Yamada Y, et al. Among authors: harashima h. Int J Pharm. 2005 Oct 13;303(1-2):1-7. doi: 10.1016/j.ijpharm.2005.06.009. Int J Pharm. 2005. PMID: 16139452 Free article.

6

Delivery of condensed DNA by liposomal non-viral gene delivery system into nucleus of dendritic cells.

Nakamura T, Moriguchi R, Kogure K, Minoura A, Masuda T, Akita H, Kato K, Hamada H, Ueno M, Futaki S, Harashima H. Nakamura T, et al. Among authors: harashima h. Biol Pharm Bull. 2006 Jun;29(6):1290-3. doi: 10.1248/bpb.29.1290. Biol Pharm Bull. 2006. PMID: 16755037 Free article.

7

Octaarginine-modified multifunctional envelope-type nano device for siRNA.

Nakamura Y, Kogure K, Futaki S, Harashima H. Nakamura Y, et al. Among authors: harashima h. J Control Release. 2007 Jun 22;119(3):360-7. doi: 10.1016/j.jconrel.2007.03.010. Epub 2007 Mar 23. J Control Release. 2007. PMID: 17478000

8

A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway.

Mudhakir D, Akita H, Tan E, Harashima H. Mudhakir D, et al. Among authors: harashima h. J Control Release. 2008 Jan 22;125(2):164-73. doi: 10.1016/j.jconrel.2007.10.020. Epub 2007 Nov 4. J Control Release. 2008. PMID: 18054812

9

Octaarginine-modified liposomes: enhanced cellular uptake and controlled intracellular trafficking.

Khalil IA, Kogure K, Futaki S, Harashima H. Khalil IA, et al. Among authors: harashima h. Int J Pharm. 2008 Apr 16;354(1-2):39-48. doi: 10.1016/j.ijpharm.2007.12.003. Epub 2007 Dec 14. Int J Pharm. 2008. PMID: 18242018 Review.

10

Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.

Nakamura T, Moriguchi R, Kogure K, Shastri N, Harashima H. Nakamura T, et al. Among authors: harashima h. Mol Ther. 2008 Aug;16(8):1507-14. doi: 10.1038/mt.2008.122. Epub 2008 Jun 17. Mol Ther. 2008. PMID: 18560420 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

628 results

Search Page

Filters